TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083.

Todd T Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.